Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

ClinicalTrials.gov ID: NCT01360021

Public ClinicalTrials.gov record NCT01360021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Double-blind, Randomized, Multi-centre, Parallel-group Study Evaluating the Efficacy Safety, and Patient Use (User Study) of Symbicort® (Budesonide/Formoterol) Breath Actuated Metered Dose Inhaler (BA MDI) 2x160/4.5 μg Twice Daily Compared With Symbicort (Budesonide/Formoterol) AC (Actuation Counter) pMDI® 2x160/4.5 μg Twice Daily and Budesonide AC pMDI 2x160 μg Twice Daily in Adult and Adolescent Asthmatics

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a comparison of the efficacy of the Symbicort breath actuated dose inhaler to the Symbicort pressured meter dose inhaler after 12 weeks of a twice a day dose.

Study identification

NCT ID
NCT01360021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
214 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2011 (Type not available)
Primary completion
Aug 2012 (Actual)
Completion
Aug 2012 (Actual)
Last update posted
Mar 11, 2014

2011 – 2012

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Research Site Huntington Beach California — —
Research Site Long Beach California — —
Research Site Los Angeles California — —
Research Site Orange California — —
Research Site Rancho Mirage California — —
Research Site Riverside California — —
Research Site Sacramento California — —
Research Site San Diego California — —
Research Site San Jose California — —
Research Site Tallahassee Florida — —
Research Site Savannah Georgia — —
Research Site River Forest Illinois — —
Research Site Louisville Kentucky — —
Research Site Metairie Louisiana — —
Research Site Bangor Maine — —
Research Site Wheaton Maryland — —
Research Site North Dartmouth Massachusetts — —
Research Site Columbia Missouri — —
Research Site Rolla Missouri — —
Research Site Skillman New Jersey — —
Research Site North Syracuse New York — —
Research Site Rochester New York — —
Research Site Cincinnati Ohio — —
Research Site Collegeville Pennsylvania — —
Research Site Lincoln Rhode Island — —
Research Site Charleston South Carolina — —
Research Site Spartanburg South Carolina — —
Research Site Dallas Texas — —
Research Site Tacoma Washington — —
Research Site Greenfield Wisconsin — —
Research Site Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01360021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2014 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01360021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →